The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype

被引：0
|
作者：
Kenjiro Aogi
Masayuki Yoshida
Yoshiaki Sagara
Shunji Kamigaki
Minoru Okazaki
Jumpei Funai
Toshio Fujimoto
Masakazu Toi
Toshiaki Saeki
Shigemitsu Takashima
机构：
[1] Shikoku Cancer Center,Department of Breast Oncology
[2] Seirei Hamamatsu General Hospital,Department of Breast Surgery
[3] Sagara Hospital,Division of Breast Surgery
[4] Sakai Municipal Hospital,Department of Surgery
[5] Sapporo Breast Surgical Clinic,Science Communications
[6] Eli Lilly Japan K.K.,Medical Science
[7] Eli Lilly Japan K.K.,Department of Surgery
[8] Kyoto University Graduate School of Medicine,Department of Breast Oncology
[9] Saitama Medical University International Medical Center,undefined
[10] Shikoku Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Anthracycline-pretreated metastatic breast cancer; Triple negative; Gemcitabine; Paclitaxel; Phase I/II trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1007 / 1015
页数：8
相关论文
共 50 条
  • [31] Efficacy of first-line bevacizumab (BEV)-based therapy for metastatic triple-negative breast cancer (TNBC): Subgroup analysis of TURANDOT
    Inbar, Moshe J.
    Lang, Istvan
    Kahan, Zsuzsanna
    Greil, Richard
    Beslija, Semir
    Stemmer, Salomon M.
    Kaufman, Bella
    Ahlers, Silke
    Brodowicz, Thomas
    Zielinski, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer
    Haiderali, Amin
    Huang, Min
    Pan, Wilbur
    Akers, Katherine G.
    Maciel, Dylan
    Frederickson, Andrew M.
    FUTURE ONCOLOGY, 2024, 20 (22) : 1587 - 1600
  • [33] Capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer: A phase III trial (CAPItello-290)
    Schmid, Peter
    Cortes, Javier
    Robson, Mark
    Iwata, Hiroji
    Hegg, Roberto
    Verma, Sunil
    Nechaeva, Marina
    Xu, Binghe
    Haddad, Vincent
    Imedio, Esteban Rodrigo
    Schiavon, Gaia
    Foxley, Andrew
    Park, Yeon Hee
    CANCER RESEARCH, 2020, 80 (04)
  • [34] A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290).
    Schmid, Peter
    Cortes, Javier
    Robson, Mark E.
    Iwata, Hiroji
    Hegg, Roberto
    Nechaeva, Marina
    Xu, Binghe
    Verma, Sunil
    Haddad, Vincent
    Imedio, Esteban Rodrigo
    Schiavon, Gaia
    Foxley, Andrew
    Park, Yeon Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] tnAcity: A phase 2/3 randomized study of weekly nab-paclitaxel in combination with either gemcitabine or carboplatin vs gemcitabine/carboplatin as first-line treatment for triple-negative metastatic breast cancer
    Yardley, D. A.
    Brufsky, A.
    Conte, P.
    Cortes, J.
    Glueck, S.
    Nabholtz, J-Ma
    O'Shaughnessy, J.
    Li, L.
    Barton, D.
    Fandi, A.
    Harbeck, N.
    CANCER RESEARCH, 2013, 73
  • [36] Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer
    Luhn, Patricia
    Chui, Stephen Y.
    Hsieh, Fu-Chi
    Yi, Jingbo
    Mecke, Almut
    Bajaj, Preeti S.
    Hasnain, Waseem
    Falgas, Adeline
    Ton, Thanh G. N.
    Kurian, Allison W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (14) : 1173 - 1185
  • [37] An Evaluation of the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2+Metastatic Breast Cancer
    Esteva, F. J.
    Franco, S. X.
    Hagan, M. K.
    Somer, R. A.
    Dombroski, C. S.
    Florance, A. M.
    Turner, S. J.
    Stein, S.
    Perez, A.
    CANCER RESEARCH, 2009, 69 (24) : 793S - 793S
  • [38] Safety and efficacy of the combination of trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: phase II results
    Michalaki, V.
    Gennatas, S.
    Gennatas, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 276 - 276
  • [39] Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients
    Luiz Gustavo Oliveira Brito
    Jurandyr Moreira de Andrade
    Thiago Lins-Almeida
    Fábio Eduardo Zola
    Mariana Novaes Pinheiro
    Heitor Ricardo Cosiski Marana
    Daniel Guimarães Tiezzi
    Fernanda Maris Peria
    Medical Oncology, 2012, 29 : 33 - 38
  • [40] Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients
    Oliveira Brito, Luiz Gustavo
    de Andrade, Jurandyr Moreira
    Lins-Almeida, Thiago
    Zola, Fabio Eduardo
    Pinheiro, Mariana Novaes
    Cosiski Marana, Heitor Ricardo
    Tiezzi, Daniel Guimaraes
    Peria, Fernanda Maris
    MEDICAL ONCOLOGY, 2012, 29 (01) : 33 - 38
12345